HCV Viral Hepatitis, Blood Sugar Level and Systolic Blood Pressure in Egypt

CompletedOBSERVATIONAL
Enrollment

71,975

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

December 31, 2018

Study Completion Date

January 31, 2019

Conditions
Hepatitis C, AcuteDiabetesHypertension
Interventions
DIAGNOSTIC_TEST

BIOLINE HCV kits

We used BIOLINE HCV kits to detect the presence of HCV antibodies in stick blood samples of all recruited patients.

DIAGNOSTIC_TEST

ACCU-CHEK kits

For all patients, we measured random blood sugar levels by stick blood samples using ACCU-CHEK kits.

DIAGNOSTIC_TEST

ErKameter 3000 mercury manometer

For all patients, we measured systolic blood pressure using ErKameter 3000 mercury manometer.

Trial Locations (1)

01234567

Egyptian Ministry of Health, Asyut

All Listed Sponsors
lead

Cairo University

OTHER

NCT03839979 - HCV Viral Hepatitis, Blood Sugar Level and Systolic Blood Pressure in Egypt | Biotech Hunter | Biotech Hunter